Long-Term Safety and Durability of Effect With a Combination of Olanzapine and Samidorphan in Patients With Schizophrenia: Results From a 1-Year Open-Label Extension Study.

Long-Term Safety and Durability of Effect With a Combination of Olanzapine and Samidorphan in Patients With Schizophrenia: Results From a 1-Year Open-Label Extension Study. CNS Spectr. 2020 May 12;:1-31 Authors: Yagoda S, Graham C, Simmons A, Arevalo C, Jiang Y, McDonnell D PMID: 32393412 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32393412?dopt=Abstract

Source: CNS Spectrums - May 11, 2020 Category: Neurology Authors: Yagoda S, Graham C, Simmons A, Arevalo C, Jiang Y, McDonnell D Tags: CNS Spectr Source Type: research

More News: Neurology | Schizophrenia | Study | Zyprexa